Nelson Hardiman has earned a singular reputation in advising laboratories on risk, compliance, and other business and regulatory issues. Diagnostic testing has been both an area of exciting breakthroughs in technology, and an epicenter of risk as government and insurance companies seek to root out suspected fraud and abuse. Nelson Hardiman has comprehensive experience guidance clients to build robust businesses and avoiding risk, as well as stepping into crises to address allegations as they arise. The firm works with many laboratories, as well as physician office labs and hospital labs, including in specialized areas such as molecular diagnostics, genomics and genetics testing, toxicology drug testing, mobile diagnostics, full-panel allergen screening, and serology-based wellness assessments. As market forces continue to drive consolidation in the diagnostics and reference laboratory industry, Nelson Hardiman advises on M&A and provides regulatory guidance for through the acquisition process, including changes of ownership (CHOWs).